SciELO - Scientific Electronic Library Online

 
vol.38 número6Gastrostomía endoscópica para el soporte nutricional en la disfagia posterior a un accidente cerebrovascularEfecto de la COVID-19 en la prescripción dietoterapéutica durante el primer semestre de 2020 en la Comunidad de Madrid índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Nutrición Hospitalaria

versão On-line ISSN 1699-5198versão impressa ISSN 0212-1611

Resumo

IZAOLA, Olatz et al. Real-world study in oncological outpatients of an oral supplement enriched with ω-3 fatty acids — effect on quality of life and nutritional parameters. Nutr. Hosp. [online]. 2021, vol.38, n.6, pp.1132-1137.  Epub 07-Fev-2022. ISSN 1699-5198.  https://dx.doi.org/10.20960/nh.03514.

Background:

cancer patients are a group at high nutritional risk. Oral nutritional supplementation (ONS) can improve nutritional status.

Objective:

the objective of our study was to evaluate the effectiveness on nutritional parameters and quality of life of a ω-3-enriched ONS in oncology outpatients in a real-world study.

Material and methods:

a total of 35 outpatient cancer patients who received 2 ONS per day were recruited. Chemistry, anthropometric, impedance measurement, nutritional survey, malnutrition universal screening tool (MUST) test, and EQ5D quality of life test were all used before and after 3 months of intervention.

Results:

mean age was 65.4 ± 10.7 years (18 females/17 males). Mean completion of the group was 81.7 ± 7.2 %. During the intervention, total protein (1.5 ± 0.2 g/dL; p = 0.01), albumin (0.9 ± 0.1 mg/dL; p = 0.04), and transferrin (53.9 ± 21.1 mg/dL; p = 0.02) levels increased. At the beginning of the study, 100 % of the patients were in the high nutritional risk category according to MUST. After the intervention, 34.3 % (n = 12) were in the low nutritional risk category, 51.4 % (n = 18) in the moderate nutritional risk category, and only 14.3 % (n = 5) in the category of high nutritional risk; previously, 100 % of patients had high nutritional risk (p = 0.02). The total score in the quality of life test increased significantly (0.51 ± 0.06 vs 0.84 ± 0.03 points; p = 0.01), with improvement in 5 dimensions.

Conclusions:

the use of a ω-3-enriched ONS in a real-world study with cancer outpatients showed a beneficial effect on nutritional parameters and quality of life.

Palavras-chave : Ambulatory; ω-3 fatty acids; Cancer; Real-world study; Quality of life.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )